France’s Sanofi to buy U.S. biopharma group Blueprint for up to $9.5-billion
- Posted on June 2, 2025
- By The Globe and Mail
- 1 Views
France’s Sanofi to buy U.S. biopharma group Blueprint for up to $9.5-billion
The deal is the largest by a European health care company this year, and is meant to add to Sanofi’s portfolio of drugs for rare immunology diseases
